Skip to content

Author

M. Meazza Prina

We have 3 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy.

BACKGROUND Composite scores such as Lung Immune Prognostic Index (LIPI), modified Glasgow Prognostic Score (mGPS), EPSILoN, Pan Immune-Inflammation Value (PIV) and Systemic Immune-Inflammation Index (SII) have shown prognostic value in solid tumors, but evidence in extensive-stage small-cell lung cancer (ES-SCLC) are l...

Teresa Beninato, Giulia Stasi, G. Montelatici et al. · 0 citations
Sep 2026

KRAS Q61 NSCLC: When Alleles Matter.

A recent article provides the largest characterization to date of KRAS Q61-mutant NSCLC. The findings reveal clinically relevant differences between Q61 alleles and highlight the importance of interpreting KRAS mutations within their genomic context. As RAS-directed therapies evolve, understanding this heterogeneity be...

M. M. Prina, L. Mezquita · 0 citations
Open access Jul 2026

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models.

This is the first study to benchmark SLMs on Italian EHRs and investigate the role of clinical expertise in prompt engineering, offering valuable insights for the future integration of SLMs into real-world clinical workflows.

Federica Corso, V. Peppoloni, L. Mazzeo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.